Intelligent Investment
Cambridge, UK Market
Global Life Sciences Atlas
April 11, 2025 5 Minute Read

Overview
- Cambridge boasts one of Europe’s most advanced life sciences hubs. The cluster offers end-to-end capabilities and real estate infrastructure supporting the entire innovation lifecycle—from discovery to translation and at-scale commercialization.
- This is supported by networks such as Cambridge Innovation Capital, One Nucleus, Innovate Cambridge and Cambridge Ahead.
- The life sciences sector is mainly centered around the larger science parks located in the Southern cluster, whereas tech is more prevalent in the North and City Centre. Micro markets have developed in key locations, offering the full spectrum of capabilities needed to generate, attract and retain companies at different stages.
- Reflecting the trend toward the urbanization of innovation, the evolution of the fringe City Centre will play a significant part in shaping the future of the Cambridge cluster and encourage greater specialization in the existing destinations.
- It is also the future location for Cambridge Cancer Research Hospital, which will combine patient-led clinical space with three new University of Cambridge Research institutes.
Submarkets
Life Sciences Venture Capital Investment Trends
Figure 1: Life Sciences Venture Capital Funding
Life Sciences Market Stats
Figure 2: Inventory Lab/R&D (Cambridge)
Development Pipeline or Activity
Figure 3: Supply Lab/R&D
Figure 4: Life Sciences Development Pipeline
- Abcam
- Altos Labs
- Amgen
- Astex
- AstraZeneca
- Bicycle Therapeutics
- Charles River Lab
- Dr Reddys
- Illumina
- Mission Therapeutics
- MundiPharma
- Nuclera
- Takeda
- Thermo Fisher
- Addenbrookes Hospital
- Anglia Ruskin University
- Cancer Research UK
- European Bio-informatics Institute
- Heart and Lung Institute
- Royal Papworth Hospital
- The University of Cambridge
- The-Milner-Institute Wellcome Sanger Cancer Research